Mediracer receives US FDA clearance for Mediracer NCS device

  Mediracer is preparing to enter the US market after the US Food and Drug Administration (FDA) 510(k) review for premarket notification for the Mediracer® NCS device was successfully completed (SE) and clearance to market the device in the US was granted. The...
College of Podiatry Conference 2019

College of Podiatry Conference 2019

We are proud to assist The College of Podiatry Conference with our distributor Henry Schein The College of Podiatry Conference is one of the most important events of the year for podiatrists. In 2018 over 1,350 colleagues attended and profited from the latest...

Mediracer® NCS system was successfully completed (SE) FDA 510(k) review

Mediracer is preparing to enter the US market after the FDA 510(k) review for premarket notification for the Mediracer® NCS system was successfully completed (SE) for our CTS Carpal Tunnel Syndrome and DPN Diabetic Peripheral Neuropathy measurement. Section 510(k) of...